There may be ‘good news’ coming for Apple Watch users in the US

A long-standing patent dispute between Apple and Masimo over blood oxygen technology in the Apple Watch may be nearing a resolution with the recent resignation of Masimo’s CEO, Joe Kiani. Earlier this year, the Cueprtino-based tech giant was ordered to remove the blood oxygen feature from upcoming Apple Watch models in the US due to this patent dispute. However, the recent resignation of the medical equipment maker’s CEO may open up possibilities for a resolution between the two companies, potentially leading to the return of blood oxygen measurement features in the upcoming Apple Watch models.